Who owns Acorda Therapeutics?

Key details on Acorda Therapeutics (Ticker: ACOR)

Who owns Acorda Therapeutics?

Is ACOR a good stock to own? Find out who bought Acorda Therapeutics, who sold Acorda Therapeutics (ACOR) stock, and who holds a large position in Acorda Therapeutics.

Fund Name Number of Shares Share Valuation As Of
FMR 4.28M $162.34M March 31, 2014
BlackRock Fund Advisors 2.79M $105.95M March 31, 2014
Vanguard 2.77M $105.13M March 31, 2014
Adage Capital Partners GP 2.71M $64.60M Dec. 31, 2011
UBS GLOBAL ASSET MANAGEMENT AMERICAS 2.66M $100.98M March 31, 2014
Damian Sousa 2.39M $80.62M June 30, 2014
Oracle Investment Management 1.96M $74.17M March 31, 2014
Invus Public Equities Advisors 1.70M $54.93M June 30, 2011
Bridger Management 1.50M $39.83M March 31, 2012
STATE STREET CORPORATION 1.39M $52.68M March 31, 2014
Ulys 1.30M $34.52M March 31, 2012
Inves 1.25M $47.48M March 31, 2014
BlackRock Institutional Trust Company, N.A. 1.20M $45.58M March 31, 2014
Wellington Management Company 1.18M $44.65M March 31, 2014
GOLDMAN SACHS 1.16M $43.80M March 31, 2014
Artal Group S.A. 1.10M $37.45M Sept. 30, 2013
Thompson, Siegel, & Walmsley 1.05M $30.73M Dec. 31, 2013
Barclays 1.04M $24.75M Dec. 31, 2011
BlackRock Advisors 1.03M $35.32M Sept. 30, 2013
Baker Bros. Advisors 1000000 $37.91M March 31, 2014
ClearBridge Advisors 997820 $37.83M March 31, 2014
Franklin Resources 942450 $35.73M March 31, 2014
Camber Capital Management 938000 $24.02M Sept. 30, 2012
Thrivent Financial for Lutherans 891100 $33.78M March 31, 2014
Millennium Management 861086 $20.53M Dec. 31, 2011

Who sold Acorda Therapeutics?

Fund Name Date Sold Number of Shares Sold Share Valuation
Name Passport Capital Sept. 30, 2011 1.11M $22.20M
S.A.C. Capital Advisors June 30, 2011 2.36M $76.31M
Brookside Capital Management, LLC* June 30, 2011 1.39M $44.78M
Wells Fargo & Company March 31, 2011 2.34M $53.62M
Westfield Capital Management Company Dec. 31, 2010 1.77M $48.24M
Senator Investment Dec. 31, 2010 1.23M $33.39M
Columbia Wanger Asset Management Dec. 31, 2010 1.17M $31.91M
CALAMOS ADVISORS Dec. 31, 2010 940000 $25.62M